Evidence map›Paper›PMID 35782994›Full record

ArticleJournal of tissue engineering

Engineering Functional Vascularized Beige Adipose Tissue from Microvascular Fragments of Models of Healthy and Type II Diabetes Conditions.

Francisca M Acosta, Katerina Stojkova, Jingruo Zhang, Eric Ivan Garcia Huitron, Jean X Jiang, Christopher R Rathbone, Eric M Brey

Open access · goldAbstract read
In one paragraph

Article in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Recent Advances in Nanozymes Toward Diabetic Foot Ulcers.International journal of nanomedicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Francisca M AcostaDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.
Katerina StojkovaDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.
Jingruo ZhangDepartment of Biochemistry and Structural Biology, University of Texas Health Science Center, San Antonio, TX, USA.
Eric Ivan Garcia HuitronDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.
Jean X JiangDepartment of Biochemistry and Structural Biology, University of Texas Health Science Center, San Antonio, TX, USA.
Christopher R RathboneDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.
Eric M BreyDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0001-8766-7390
The University of Texas Health Science Center at San Antonio · USThe University of Texas at San Antonio · US

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
AN ENABLING TECHNOLOGY FOR PRECLINICAL X-RAY IMAGING OF BIOMATERIALS IN-VIVOR01EB020604 · NIBIB · WASHINGTON UNIVERSITY · PI ANASTASIO, MARK A, BREY, ERIC M · 2016 to 2019
$2.3M
Elucidating Skeletal Muscle Satellite Cell:Microvessel Interactions in Diabetic MuscleSC1DK122578 · NIDDK · UNIVERSITY OF TEXAS SAN ANTONIO · PI RATHBONE, CHRISTOPHER RONALD · 2019 to 2022
$1.5M
BLRD VA I01 BX000418NCI NIH HHS T32 CA148724NIBIB NIH HHS R01 EB020604NIDDK NIH HHS SC1 DK122578NIGMS NIH HHS R25 GM060655
6 · The paper itself

Abstract

Engineered beige adipose tissues could be used for screening therapeutic strategies or as a direct treatment for obesity and metabolic disease. Microvascular fragments are vessel structures that can be directly isolated from adipose tissue and may contain cells capable of differentiation into thermogenic, or beige, adipocytes. In this study, culture conditions were investigated to engineer three-dimensional, vascularized functional beige adipose tissue using microvascular fragments isolated from both healthy animals and a model of type II diabetes (T2D). Vascularized beige adipose tissues were engineered and exhibited increased expression of beige adipose markers, enhanced function, and improved cellular respiration. While microvascular fragments isolated from both lean and diabetic models were able to generate functional tissues, differences were observed in regard to vessel assembly and tissue function. This study introduces an approach that could be employed to engineer vascularized beige adipose tissues from a single, potentially autologous source of cells.

Indexed as

Beige adipose tissuefatmicrovascular fragmentstissue engineeringtype 2 diabetes

Identifiers

PMID35782994
PMCPMC9248044
OpenAlexW4283837731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.